Patient Power’s Andrew Schorr survived leukemia in-part because of the treatment he received while participating in a phase II clinical trial. He received a now-FDA-approved combination treatment ten years before it was approved. Clinical trials may not be the right answer for you, but they are an important consideration, especially when facing an incurable or life-altering condition. You may have the opportunity to receive “tomorrow’s medicine today” and by participating you can help advance knowledge about your condition, all while receiving close monitoring and the best care available.
Including conversation regarding clinical trials
Clinical Trials for PKU